Invention Grant
- Patent Title: Human antibodies to GFRα3 and methods of use thereof
- Patent Title (中): GFRα3的人抗体及其使用方法
-
Application No.: US13971965Application Date: 2013-08-21
-
Publication No.: US08968736B2Publication Date: 2015-03-03
- Inventor: Susan D. Croll , Lynn Macdonald , Andrew J. Murphy
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Brownstein Hyatt Farber Schreck, LLP
- Agent Cara L. Crowley-Weber; Veronica Mallon
- Main IPC: C07K16/00
- IPC: C07K16/00 ; C12P21/08 ; A61K39/395 ; A61K39/00 ; C07K16/28 ; A61K45/06
Abstract:
The present invention provides antibodies that bind to human GFRα3 and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human GFRα3. The antibodies of the invention are useful for the treatment of diseases and disorders associated with one or more GFRα3 biological activities, including the treatment of acute or chronic pain conditions, or inflammatory conditions.
Public/Granted literature
- US20140056903A1 HUMAN ANTIBODIES TO GFR ALPHA 3 AND METHODS OF USE THEREOF Public/Granted day:2014-02-27
Information query
